Prognostic indices for budd-chiari syndrome: Valid for clinical studies but insufficient for individual management

American Journal of Gastroenterology

Volumn 104, Issue 5, 2009, Pages 1140-1146

  Rautou, Pierre Emmanuel ^a   Moucari, Rami ^a   Escolano, Sylvie ^b   Cazals Hatem, Dominique ^c   Denié, Cécile ^d   Chagneau Derrode, Carine ^e   Charpignon, Claire ^e   Lédinghen, Victor De ^f   Grenouillet Delacre, Marieke ^g   Habersetzer, François ^h   Nousbaum, Jean Baptiste ⁱ   Denninger, Marie Hélène ^c   Valla, Dominique C ^a,c   Plessier, Aurélie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c BEAUJON HOSPITAL   (France)

^d Centre Hospitalier du Grand Hornu   (Belgium)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f Service d'Hépato gastroentérologie   (France)

^g HÔPITAL SAINT ANDRÉ   (France)

^h HÔPITAL CIVIL   (France)

ⁱ SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ARTICLE; BOOTSTRAPPING; BUDD CHIARI SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TIME; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VALIDATION PROCESS; AREA UNDER THE CURVE; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; HOSPITALIZATION; LIVER FUNCTION TEST; METHODOLOGY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; VALIDATION STUDY; VASCULAR PATENCY;

ADULT; AREA UNDER CURVE; BUDD-CHIARI SYNDROME; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 66949120704     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.63     Document Type: Article

References (30)

1. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003;38:793-803.
2. Zeitoun G, Escolano S, Hadengue A et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-9.
3. Langlet P, Escolano S, Valla D et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39: 496-501.
4. Murad SD, Kim WR, de Groen PC et al. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transplant 2007;13:867-74.
5. Murad SD, Valla DC, de Groen PC et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-8.
6. Valla D. Hepatic venous outflow tract obstruction etiopathogenesis: Asia vs. the West. J Gastroenterol Hepatol 2004;19:S204-S11.
7. Deltenre P, Denninger MH, Hillaire S et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001;48:264-8.
8. Plessier A, Sibert A, Consigny Y et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44: 1308-16.
9. Bachet JB, Condat B, Hagege H et al. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007;46:60-8.
10. Garcia-Pagan JC, Heydtmann M, Raffa S et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135:808-15.
11. Moucari R, Rautou PE, Cazals-Hatem D et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008;57:828-35.
12. Janssen HL, Garcia-Pagan JC, Elias E et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-71.
13. Denninger MH, Chait Y, Casadevall N et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-91.
14. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
15. Malinchoc M, Kamath PS, Gordon FD et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71.
16. Kovacs MJ, Wong A, MacKinnon K et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 1994;71:727-30.
17. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996;24:1392-4.
18. Kiladjian JJ, Cervantes F, Leebeek FW et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases. Blood 2008;111:4922-9.
19. Heinzl H. Using SAS to calculate the Kent and O'Quigley measure of dependence for Cox proportional hazards regression model. Comput Methods Programs Biomed 2000;63:71-6.
20. Altman DG, Andersen PK. Bootstrap investigation of the stability of a Cox regression model. Stat Med 1989;8:771-83.
21. Steyerberg EW, Harrell FE Jr, Borsboom GJ et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-81.
22. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 2001;122:430-9.
23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
24. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
25. DAmico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-31.
26. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
27. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805.
28. Davison AC, Hinkley DV Bootstrap Methods and Their Applications. Cambridge, UK, 1997.
29. Eapen CE, Velissaris D, Heydtmann M et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006;55:878-84.
30. Valla DC. Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage. Gut 2006;55:761-3.